Julie Bullock
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 3
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments 7
- Multiple Myeloma Research and Treatments 2
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 5
- Oncology top 5%
- Statistics and Probability top 5%
- Statistical Methods in Clinical Trials 4
-
- Acute Lymphoblastic Leukemia research 4
-
- Lymphoma Diagnosis and Treatment 3
-
- Neuroendocrine Tumor Research Advances 2
- Co-authors
- Richard PazdurJoseph A. GrilloAnn T. FarrellEdvardas KaminskasSatjit BrarEva Gil BerglundPing ZhaoRajeshwari Sridhara
- Cited by
- PharmacologyHematologyGenetics
- Partner nations
- United StatesSwedenCanada
In The Last Decade
Julie Bullock
26 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 111
- Pharmacology 278
- Hematology 356
- Genetics 244
- Oncology 515
- Statistics and Probability 89
Countries citing papers authored by Julie Bullock
This map shows the geographic impact of Julie Bullock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Bullock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Bullock more than expected).
Fields of papers citing papers by Julie Bullock
This network shows the impact of papers produced by Julie Bullock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Bullock. The network helps show where Julie Bullock may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Julie Bullock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 2 | |
| 3 | 2022 | 3 | |
| 4 | 2014 | 32 | |
| 5 | 2012 | 107 | |
| 6 | 2012 | 83 | |
| 7 | 2011 | 3 | |
| 8 | 2010 | 402 | |
| 9 | 2010 | 38 | |
| 10 | 2008 | 25 | |
| 11 | 2008 | 190 | |
| 12 | 2008 | 48 | |
| 13 | 2007 | 85 | |
| 14 | 2006 | 18 | |
| 15 | 2005 | 37 | |
| 16 | 2004 | 95 | |
| 17 | 2004 | 16 | |
| 18 | 2004 | 32 | |
| 19 | 2003 | 1 | |
| 20 | 1968 | 2 |
About Julie Bullock
Julie Bullock is a scholar working on Hematology, Genetics and Statistics and Probability, having authored 26 papers that have together received 1.6k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (7 papers), Chronic Lymphocytic Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (4 papers), Statistical Methods in Clinical Trials (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Neuroendocrine Tumor Research Advances (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Pharmacology (278 citations), Hematology (356 citations) and Genetics (244 citations). Julie Bullock has collaborated with scholars based in United States, Sweden and Canada. Frequent co-authors include Richard Pazdur, Joseph A. Grillo, Ann T. Farrell, Edvardas Kaminskas, Satjit Brar, Eva Gil Berglund, Ping Zhao, Rajeshwari Sridhara, Patrick F. Smith and Brent M. Booker. Their work appears in journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.